Moshe Giladi

Insider Reports History

Location
Sh'ar Hacarmel, Haifa, Israel
Signature
Steven Robbins, as attorney in fact for Giladi, Moshe
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Moshe Giladi:

Form 4 holding Chief Science Officer

NovoCure Ltd

Security class
Stock Options (Right to buy)
Shares / value
78,174
Estimated value
$1,274,236
Report date
27 Feb 2024
Price
$16.30
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
Form 4 holding Chief Science Officer

NovoCure Ltd

Security class
Ordinary Shares
Shares / value
69,771
Estimated value
$1,137,267
Report date
27 Feb 2024
Price
$16.30
Ownership
Direct
Form 4 holding Chief Science Officer

NovoCure Ltd

Security class
Restricted Share Units
Shares / value
353
Estimated value
Report date
26 Jul 2023
Price
Ownership
Direct

Insider Reports Filed by Moshe Giladi

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .